 Shares of micro-cap biopharma Immunome Inc NASDAQ: IMNM are indicated to open Thursdays session sharply higher. What Happened: Immunome, which focuses on developing antibody therapies, said its discovery engine has isolated potent antibodies capable of neutralizing several SARS-CoV-2 variants, including the South African Variant B.1.351, in pseudovirus testing. 